RANDOMIZED STUDY OF STEREOTACTIC BODY RADIATION THERAPY (SBRT) VERSUS TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELLUAR CARCINOMA

Primary Sponsor

Trial Contact

qa@trog.com.au

Related Post

26 March, 2026

TROG welcomes new Board members and President-Elect

LATEST NEWS: 26 March 2026 We are delighted to

26 March, 2026

TROG’S 38th ASM puts focus on driving innovative trials

LATEST NEWS: 26 March 2026 TROG’s 2026 Annual Scientific